Announcements
Oncology World Mourns the Loss of Jimmie C. Holland, MD, Founder, Field of Psycho-Oncology
The ASCO Post
Jimmie C. Holland, MD, died suddenly on December 24, 2017, at the age of 89 years. Dr. Holland was the Attending Psychiatrist and Wayne E. Chapman Chair at Memorial Sloan Kettering (MSK) Cancer Center and Professor of Psychiatry, Weill Medical College of Cornell University in New York. Internationa...
Narratives in Oncology
The ASCO Post
Keith Witmer received his Bachelor’s degree in Fine Arts from Otis/Parsons School of Design. He subsequently launched his career in advertising and publication with a commanding presence, initially using pen and ink and scratchboard mediums. Working with clients such as FedEx, pple Computer, Hewle...
ASCO Presidents Through the Years
The ASCO Post
2016–2017 Daniel Hayes, MD 2015–2016 Julie Vose, MD, MBA 2014–2015 Peter Paul Yu, MD, FACP 2013–2014 Clifford A. Hudis, MD, FACP 2012–2013 Sandra M. Swain, MD 2011–2012 Michael P. Link, MD 2010–2011 George W. Sledge, Jr, MD 2009–2010 Douglas W. Blayney, M...
ASCO Honors Leaders in Cancer Care With 2019 Special Awards
The ASCO Post
ASCO and ASCO’s Conquer Cancer Foundation are proud to recognize the winners of ASCO’s Special Awards and Conquer Cancer’s Women Who Conquer Cancer Mentorship Awards and Tribute Award. The recipients of these awards have worked to transform cancer care around the world. Don’t miss the opportunity t...
MD Anderson Cancer Center Marks 75 Years of Research to End Cancer
The ASCO Post
In November, The University of Texas MD Anderson Cancer Center celebrated its 75th anniversary with a week-long series of events that raised nearly $15 million to support its efforts in patient care and in the investigation and treatment of cancer. Housed on 16 million square feet in the city of Hou...
The US Oncology Network Promotes Marcus Neubauer, MD, to Chief Medical Officer
The ASCO Post
THE US ONCOLOGY Network recently announced the appointment of Marcus Neubauer, MD, as Chief Medical Officer, building on its mission of delivering a comprehensive approach to cancer care. Michael Seiden, MD, PhD, will continue to lead The US Oncology Network as its President. Dr. Neubauer has be...
ASH 2017 Outstanding Service and Public Service Awards
The ASCO Post
The American Society of Hematology (ASH) presented the 2017 awards for outstanding service and public service on December 10 during the 59th Annual Meeting and Exposition in Atlanta. Tom Brokaw is the 2017 recipient of the ASH Outstanding Service Award, presented annually to an individual who h...
First Universal Childhood Cancer Data Lab Opens
The ASCO Post
ALEX’S LEMONADE STAND FOUNDATION (ALSF) has announced the opening of the first-of-its-kind Childhood Cancer Data Lab (CCDL) with the mission of accelerating cures. ALSF first announced the CCDL at the National Cancer Moonshot Summit in Washington, DC, hosted by former Vice President Joe ...
Clifford A. Hudis, MD, FACP, Named ASCO’s Next CEO
The ASCO Post
Clifford A. Hudis, MD, FACP, Chief of the Breast Medicine Service, Vice President for Government Relations, and Chief Advocacy Officer at Memorial Sloan Kettering Cancer Center (MSKCC), and Professor of Medicine at Weill Cornell Medical College, has been named the next Chief Executive Officer (C...
Lung Cancer Alliance Announces National Framework for Lung Cancer Screening Excellence
The Lung Cancer Alliance (LCA) moved lung cancer screening to a national platform by announcing a Framework for Lung Cancer Screening Excellence, which includes a bill of rights for the at-risk public and guiding principles for lung cancer screening sites. “The science is indisputable: Screening th...
Abstracts From the NCCN 2020 Annual Conference Now Available
The ASCO Post Staff
Abstracts from posters that would have been presented at the National Comprehensive Cancer Network® (NCCN®) 2020 Annual Conference are now available online. Although NCCN officials were compelled to postpone the conference in response to the coronavirus disease 2019 (COVID-19) pandemic, in order to ...
Richard L. Schilsky, MD, FACP, FSCT, FASCO, Designated a National Associate of the National Academies of Sciences, Engineering, and Medicine
The ASCO Post Staff
In February 2020, Richard L. Schilsky, MD, FACP, FSCT, FASCO, Chief Medical Officer and Executive Vice President of ASCO, was designated a National Associate of the National Academy of Sciences, Engineering, and Medicine for his decades-long contributions to the National Academy of Medicine (NAM). ...
Barry Paul Sleckman, MD, PhD, to Lead O’Neal Comprehensive Cancer Center
The ASCO Post Staff
Barry Paul Sleckman, MD, PhD, a well-known cancer researcher who focuses on understanding how DNA double-strand breaks are generated and repaired—a key topic for cancer and immune system development and function—has been named Director of the O’Neal Comprehensive Cancer Center at the University of...
Cleveland Clinic Appoints Jame Abraham, MD, FACP, as Department Chair of Hematology/Medical Oncology
The ASCO Post Staff
Jame Abraham, MD, FACP, has been appointed the new Chair of the Hematology/Medical Oncology Department at Cleveland Clinic. In this capacity, he will recruit and develop staff as well as guide the department’s focus on patient access and a multidisciplinary approach to care. Dr. Abraham currently ...
The Mark Foundation Awards $6 Million Grant for Lung Cancer Research
The ASCO Post
The Mark Foundation for Cancer Research has awarded a 3-year $6 million grant to support a new phase of discovery for a team of investigators developing, optimizing, and integrating targeted therapies and immunotherapies to improve outcomes for patients with the most common—and most difficult to t...
Rebecca Yang, MD, Joins Atlantic Health System
The ASCO Post
BREAST SURGEON Rebecca C. Yang, MD, has joined Atlantic Breast Associates at Overlook Medical Center and Carol G. Simon Cancer Center, part of Atlantic Health System Cancer Care, in New Jersey. Dr. Yang is a board-certified general surgeon and fellowship-trained breast surgeon. She joins Atlantic ...
NCCN Hits 1 Million Registered Users Accessing NCCN Guidelines® and Related Content
The ASCO Post
The National Comprehensive Cancer Network® (NCCN®) has announced that its registration count has grown to more than 1 million users. By registering on the NCCN website, users are able to view and download all of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) free of...
Nobel Prize in Physiology or Medicine: Laureates in Oncology
The ASCO Post
The Nobel Prize in Physiology or Medicine has been awarded to many individuals whose research directly impacted the understanding of cancer: In 2008 to Harald zur Hausen, for his discovery of human papillomavirus causing cervical cancer In 2005 to J. Robin Warren and Barry J. Marshall, for their...
Dr. Larry Norton, Honored at 2013 Breast Cancer Symposium, Calls For A Return to the 'Exploration of Concepts'
Caroline Helwick
Larry Norton, MD, of Memorial Sloan-Kettering Cancer Center, is the recipient of the 2013 Gianni Bonadonna Breast Cancer Award, which he received at the 2013 Breast Cancer Symposium. The Symposium is sponsored by ASCO, the American Society of Breast Surgeons, the American Society of Radiation Oncolo...
NCCN Appoints Dr. Robert Carlson as Chief Executive Officer
The ASCO Post
The National Comprehensive Cancer Network (NCCN) has appointed Robert W. Carlson, MD, a leading expert in the field of breast medical oncology, as Chief Executive Officer. “Dr. Carlson is highly regarded in the oncology community, and NCCN is extremely pleased to appoint him as CEO. Over the last 1...
Senate Legislation Urges Federal Research Support to Improve Early Detection of Prostate Cancer
The ASCO Post
U.S. Senator John F. Kerry (D-MA) led unanimous passage of Senate Resolution 493 to recognize prostate cancer as an epidemic striking African American men disproportionately, with 250% higher mortality and 60% higher incidence. This bipartisan legislation urges federal agencies to support research f...
News From the Centers for Medicare & Medicaid Services
The ASCO Post
The Centers for Medicare & Medicaid Services (CMS) recently issued final rulings on several issues relevant to prescription drug prices and Medicaid provider payments. Prescription Drug Prices On May 16, 2019, CMS issued a final rule that modernizes and improves the Medicare Advantage and Par...
ASCO Applauds NCI Announcement on Increased Funding for National Clinical Trials Network
ON JUNE 2, ASCO President Bruce E. Johnson, MD, FASCO, released the following statement: Today at the 2018 ASCO Annual Meeting, National Cancer Institute (NCI) Director Norman Sharpless, MD, announced $10 million in new funding for the National Clinical Trials Network (NCTN). ASCO applauds Dr. Sha...
NCCN Awards Nine Grants for Quality Improvement in Breast Cancer Care
The ASCO Post
THE NATIONAL COMPREHENSIVE Cancer Network® (NCCN®) Oncology Research Program in collaboration with Pfizer Global Medical Grants announced they have awarded funding to nine projects that use clinical care pathways to implement quality improvement initiatives along the continuum of care for underserve...
Daniel Von Hoff, MD, FACP, Receives Gold Medal From Columbia University
The ASCO Post
Daniel Von Hoff, MD, FACP—Distinguished Professor, Physician-in-Chief, and Director of Molecular Medicine at the Translational Genomics Research Institute—received a gold medal for excellence in clinical medicine from his alma mater, Columbia University. Columbia University College of Physicians a...
Marc S. Ernstoff, MD, Named UB Chief of Hematology/Oncology, Roswell Park Chair of Medicine
The ASCO Post
Marc S. Ernstoff, MD, has been appointed Professor and Chief of the Division of Hematology/Oncology in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) and Chair of the Department of Medicine and Senior Vice President of Clinical I...
José Baselga, MD, PhD, Inaugurated as AACR President
The American Association for Cancer Research (AACR) inaugurated José Baselga, MD, PhD, as President for 2015–2016 at the AACR Annual Meeting 2015. Dr. Baselga, an internationally recognized physician-scientist whose research focuses on the clinical development of novel molecularly targeted agents (...
ASCO Commends U.S. House of Representatives for Voting to Repeal the SGR, Urges Senate to Pass Legislation
The ASCO Post
We applaud the House of Representatives for passing legislation that eliminates the Sustainable Growth Rate [SGR] formula and takes a giant leap toward meaningful and urgently needed Medicare physician payment reform. Cancer incidence among Medicare beneficiaries is expected to increase by 67% by 20...
In Chicago for ASCO?
Robert H. Lurie Comprehensive Cancer Center of Northwestern University is celebrating the 20th Annual Cancer Survivors’ Celebration with a first! Join the Lurie Cancer Center for a timed 5K run along the lakefront on Sunday, June 2. The run will start in Chicago’s Grant Park at 7:15 AM, before the ...
Confirmation Hearing for FDA Commissioner Nominee Stephen Hahn, MD
The ASCO Post Staff
On November 20, 2019, Stephen Hahn, MD, President Trump’s nominee to be the next Commissioner of the U.S. Food and Drug Administration (FDA), appeared before the Senate Health, Education, Labor, and Pension Committee and answered wide-ranging questions relating to the many important roles the Comm...
SITC Publishes First Clinical Immunotherapy Guidelines for Treatment of Head/Neck Squamous Cell Carcinoma
The ASCO Post
The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy guidelines for squamous cell carcinoma of the head and neck, providing oncologists and other advanced practice providers with a clinical roadmap to treating this disease with immunotherapies approved in the...
Blue Distinction Center for Cellular Immunotherapy Status Granted to Huntsman Cancer Institute
The ASCO Post
Huntsman Cancer Institute (HCI) at the University of Utah is the first Regence provider designated as a national Blue Distinction Center for Cellular Immunotherapy. Chimeric antigen receptor (CAR) T-cell therapy (CAR–T)-designated hospitals must be certified by a Risk Evaluation and Mitigation S...
Rishi Jain, MD, MS, DABOM, Joins Fox Chase GI Program
The ASCO Post
Rishi Jain, MD, MS, DABOM, has joined Fox Chase Cancer Center as Assistant Professor in the Gastrointestinal (GI) Medical Oncology Program. After graduating from Fox Chase/Temple University Fellowship Training Program, Dr. Jain moved on to the Gastrointestinal Medical Oncology Program at The Ohio...
Vamsidhar Velcheti, MD, Joins NYU Langone as Director of Thoracic Medical Oncology
The ASCO Post
Clinician and researcher Vamsidhar ‘Vamsi’ Velcheti, MD, recently joined the Perlmutter Cancer Center at New York University (NYU) Langone Health as Director of Thoracic Medical Oncology. He aims to improve clinical care, increase translational and clinical research, and promote interdisciplinary ...
Hidayatullah G. Munshi, MD, Named Program Leader of Tumor Environment and Metastasis Program at Robert H. Lurie Comprehensive Cancer Center
The ASCO Post
Hidayatullah G. Munshi, MD, has been named Leader of the Tumor Environment and Metastasis (TEAM) Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The TEAM Program utilizes an integrative approach to elucidate key molecular interactions between tumor cells and c...
ASTRO to Host Virtual Annual Meeting, October 25–28, 2020
The ASCO Post Staff
The American Society for Radiation Oncology (ASTRO) has announced it will hold its 62nd Annual Meeting October 25–28, 2020, via an interactive virtual platform. The meeting, “Global Oncology: Radiation Therapy in a Changing World,” will feature reports from the latest clinical trials; panels on glob...
ASCO20 Virtual Scientific Program Convened Record Number of Oncology Professionals From Across the Globe
The ASCO Post Staff
ASCO announced record-breaking attendance at its 3-day ASCO20 Virtual Scientific Program, held online from May 29 through May 31. More than 42,700 attendees from 138 countries have participated thus far, learning virtually about new clinical cancer advances in every area of cancer research. Through...
Role of Physical Activity in Cancer Treatment and Survivorship
The ASCO Post Staff
On October 16, 2019, an expert panel convened by the American College of Sports Medicine (ACSM)released updated guidance and recommendations on the role of physical activity and exercise in cancer prevention and survivorship. The panel was co-chaired by Kathryn Schmitz, PhD, MPH, of the Department o...
ASTRO and ACR Update Practice Parameters for Radiation Therapies
The ASCO Post Staff
The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) recently released seven updated practice parameters for medical providers who use radiation therapy to treat patients with cancer. The updated practice parameters synthesize the clinical best practices th...
CDC Foundation Launches Virtual Tool to Prevent Infections in Patients With Cancer
The ASCO Post
The Centers for Disease Control and Prevention (CDC) Foundation recently launched an educational tool using virtual human technology to improve patient-provider conversations about neutropenia as a side effect of chemotherapy. This new resource is part of the Preventing Infections in Cancer Patients...
AACR Announces 2018 Special Recognition Awards
THE AMERICAN ASSOCIATION for Cancer Research (AACR) presented Special Recognition Awards to the following four individuals whose work has made extraordinary contributions to the AACR’s mission to accelerate the prevention and cure of all cancers through research, education, communication, and collab...
Seattle Children’s Hospital Opens CAR T-Cell Immunotherapy Trial in Pediatric Leukemia
The ASCO Post
Seattle Children’s Hospital has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the United States for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL). With this more robust defense, researchers hope the n...
Jeffrey Fowler, MD, Begins Presidency of Society of Gynecologic Oncology
The ASCO Post
Jeffrey Fowler, MD, John G. Boutselis Chair in Gynecologic Oncology and Professor and Vice-Chair of Obstetrics and Gynecology at The Ohio State University Wexner Medical Center, started his 1-year term as the 48th President of the Society of Gynecologic Oncology (SGO) at the conclusion of the Soci...
Mylin A. Torres, MD, Named Director of Winship’s Glenn Family Breast Center
The ASCO Post
Winship Cancer Institute of Emory University has named Mylin A. Torres, MD, the new Director of the Glenn Family Breast Center, effective January 19, 2016. She succeeds Ruth O’Regan, MD, who now heads the University of Wisconsin Division of Hematology and Oncology. Dr. Torres is Associate Professor...
U-M Cancer Center Names Bhramar Mukherjee, PhD, Associate Director for Population Science Research
The ASCO Post
The University of Michigan (U-M) Comprehensive Cancer Center has appointed Bhramar Mukherjee, PhD, as Associate Director for Population Science Research. Dr. Mukherjee is John D. Kalbfleisch Collegiate Professor of Biostatistics and Professor of Epidemiology at the U-M School of Public Health. She ...
Antoni Ribas, MD, PhD, Receives NCI Outstanding Investigator Award
The ASCO Post
UCLA Jonsson Comprehensive Cancer Center member Antoni Ribas, MD, PhD, has received a National Cancer Institute (NCI) Outstanding Investigator Award of $4.2 million in recognition of his research conducted in the development of new immunotherapies that utilize the human body’s own natural defenses ...
ASH Pairs Hematologists From Developing and Developed Nations for Global Training Program
The ASCO Post
The American Society of Hematology (ASH) recently announced the 20 hematologists and other medical professionals selected to participate in the 2014 ASH Visitor Training Program. This program provides talented hematologists, scientists, and laboratory staff from developing countries the opportunity ...
Timothy Chan, MD, PhD, Named Director of Cleveland Clinic’s Center for Immunotherapy and Precision Immuno-Oncology
The ASCO Post Staff
Timothy Chan, MD, PhD, has been appointed Director of the Center for Immunotherapy and Precision Immuno-Oncology at Cleveland Clinic. Dr. Chan will lead the new center to bring together multidisciplinary experts from across the Cleveland Clinic enterprise to advance research and treatment related to...
Ethan Basch, MD, MSc, Receives ACCC Clinical Research Award
The ASCO Post Staff
The Association of Community Cancer Centers (ACCC) 2019 Clinical Research Award was presented to Ethan Basch, MD, MSc, during the ACCC 36th National Oncology Conference held recently in Orlando, Florida. Dr. Basch is the Director of the Cancer Outcomes Research Program and Professor of Hematology ...
$5 Million Gift to Advance Ovarian Cancer Research
The ASCO Post Staff
The chairman emeritus of The Estée Lauder Companies has made a $5 million gift to the University of Arizona Cancer Center. The gift from Leonard A. Lauder supports the clinical and translational research of David S. Alberts, MD, an expert in the field of ovarian cancer research and treatment. Dr....
